| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRME | Common Stock, par value $0.001 | Purchase | $594 | +508 | +0.12% | $1.17 | 428K | Sep 13, 2023 | By Marshall & Patricia Geller Living Trust | F1, F2 |
| transaction | VRME | Common Stock, par value $0.001 | Purchase | $1.53K | +1.3K | +0.3% | $1.18 | 429K | Sep 14, 2023 | By Marshall & Patricia Geller Living Trust | F2 |
| holding | VRME | Common Stock, par value $0.001 | 52K | Sep 13, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | VRME | Restricted Stock Units | 30K | Sep 13, 2023 | Common Stock, par value $0.001 | 30K | $0.00 | By Marshall & Patricia Geller Living Trust | F3, F4 | |||||
| holding | VRME | Warrant (Right to Buy) | 7K | Sep 13, 2023 | Common Stock, par value $0.001 | 7K | $4.60 | By Marshall & Patricia Geller Living Trust | ||||||
| holding | VRME | 8% Convertible Promissory Note due 2026 | $175K | Sep 13, 2023 | Common Stock, par value $0.001 | 152K | $1.15 | By Marshall & Patricia Geller Living Trust | ||||||
| holding | VRME | Stock Option (Right to Buy) | 3K | Sep 13, 2023 | Common Stock, par value $0.001 | 3K | $5.30 | By Marshall & Patricia Geller Living Trust | F5 | |||||
| holding | VRME | Stock Option (Right to Buy) | 10K | Sep 13, 2023 | Common Stock, par value $0.001 | 10K | $3.51 | By Marshall & Patricia Geller Living Trust | F5 | |||||
| holding | VRME | Stock Option (Right to Buy) | 10K | Sep 13, 2023 | Common Stock, par value $0.001 | 10K | $3.51 | By Marshall & Patricia Geller Living Trust | F5 | |||||
| holding | VRME | Warrant (Right to Buy) | 31.1K | Sep 13, 2023 | Common Stock, par value $0.001 | 31.1K | $3.22 | By Marshall & Patricia Geller Living Trust | ||||||
| holding | VRME | Warrant (Right to Buy) | 31.9K | Sep 13, 2023 | Common Stock, par value $0.001 | 31.9K | $4.60 | By Marshall & Patricia Geller Living Trust |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17. Mr. Geller undertakes to provide VerifyMe, Inc., any security holder of VerifyMe, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | Includes (i) 86,806 shares of restricted stock that vests on 6/7/2024 and (ii) 68,310 vested restricted stock units that become payable, on a one-for-one basis, in shares of common stock of VerifyMe, Inc. upon separation of the Reporting Person's service as a director. |
| F3 | These restricted stock units, which convert into common stock on a one-for-one basis, vest on 4/7/2024 in two equal tranches, except as otherwise provided in the award notice. Tranch 1 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $5.00 for 20 consecutive trading days, Tranch 1 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days. |
| F4 | (Continued from footnote 4) Tranch 2 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $7.00 for 20 consecutive trading days, Tranch 2 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days. |
| F5 | This option is fully exercisable as of the date of this report. |